Also known as: Neurolytic Healthcare Ltd., Neurolytic Healthcare, DiveHealth, mable
First personalized migraine clinic using genetics and telehealth.
Company was acquired
Event Year: 2021
Company was acquired
Event Year: 2021
Mable was an innovative healthcare provider specializing in personalized migraine treatment. By leveraging genetic analysis and telehealth technologies, Mable aimed to identify the most effective medication for each patient, complemented by ongoing support from migraine experts. This approach sought to improve treatment outcomes and patient satisfaction. Mable reported that patients experienced significantly higher treatment satisfaction rates, gained an additional day per week free from migraine symptoms, and achieved a substantial reduction in pain. Mable's integration of DNA analysis with remote healthcare delivery represented a novel approach to managing this debilitating condition.
Mable was an innovative healthcare provider specializing in personalized migraine treatment. By leveraging genetic analysis and telehealth technologies, Mable aimed to identify the most effective medication for each patient, complemented by ongoing support from migraine experts. This approach sought to improve treatment outcomes and patient satisfaction. Mable reported that patients experienced significantly higher treatment satisfaction rates, gained an additional day per week free from migraine symptoms, and achieved a substantial reduction in pain. Mable's integration of DNA analysis with remote healthcare delivery represented a novel approach to managing this debilitating condition.
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2021
Total Raised: Unknown (Y Combinator backed)
Last Round: Summer 2021
Healthcare
Healthcare
Healthcare -> Medical Devices
Healthcare -> Medical Devices
Team size: 7
Hiring: No
Team size: 7
Hiring: No